The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study. - Herrington, William G; Preiss, David; Haynes, Richard; Eynatten, Maximilian von; Staplin, Natalie; Hauske, Sibylle J; George, Jyothis T; Green, Jennifer B; Landray, Martin J; Baigent, Colin; Wanner, Christoph (Clinical Kidney Journal, 2020)